✦ LIBER ✦

Fluoxetine in the treatment of amphetamine dependence

✍ Scribed by R. G. Polson; P. M. Fleming; J. K. O'shea

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 318 KB
Volume: 8
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.470080110

No coin nor oath required. For personal study only.

✦ Synopsis

Evidence of increasing prevalence of amphetamine mis-use, with a concomitant increase in intravenous administration of the drug, highlights the need for better alternatives to the current pharmacological interventions available for the treatment of amphetamine withdrawal symptoms, and prevention of reiapse. A number of amphetamine analogues are neurotoxic to serotonergic neural pathways. In addition, there is evidence of reduced activity in serotonergic pathways in individuals with antisocial personality disorder and substance abuse. We report on the use of fluoxetine in eight cases of whom four achieved abstinence. Three cases reported a reduction in amphetamine use and only one reported no change in the level of use. Control studies are indicated and the use of fluoxetine in relapse prevention warrants further investigation.

📜 SIMILAR VOLUMES

Tianeptine versus fluoxetine in the trea

Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease

✍ Tomasz M. Sobow; Marcin Maczkiewicz; Iwona Kloszewska 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

Beeching, 1991) , sometimes transferring their own disquietude at such discussions with relatives on to the reluctance of relatives to talk about DNR issues. Perhaps, in the UK, we need to learn from many of our American colleagues who see it appropriate to formulate an advance directive that comb

Fluoxetine treatment of depression in pa

Fluoxetine treatment of depression in patients suffering from multiple sclerosis

✍ Yoram Barak; Anat Achiron; David Shoshani; Avner Elizur 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Open fixed dose trial of fluoxetine in t

Open fixed dose trial of fluoxetine in the treatment of obsessive compulsive disorder

✍ Suck Won Kim; Maurice W. Dysken 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

Effectiveness of fluoxetine and doxepin

Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients

✍ Paul Sandor; Brian Baker; Jane Irvine; Paul Dorian; D. McKessok; S. Mendlowitz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

It has been suggested that serotonin reuptake inhibitors (SSRIs) may be less effective than tricyclic antidepressants (TCAs) in treatment of melancholic depression. We treated 36 depressed ambulatory patients with doxepin or fluoxetine in a double-blind, randomized 6-week trial with placebo run-in.

A randomized, double-blind comparison of

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

✍ Sara A. Corya; Doug Williamson; Todd M. Sanger; Susan D. Briggs; Michael Case; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Fluoxetine versus Vitex agnus castus ext

Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder

✍ Murad Atmaca; Selahattin Kumru; Ertan Tezcan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

## Abstract Clinical trials have demonstrated that serotonin reuptake inhibitors (SRIs) and the extract of __Vitex agnus castus__ are effective for the treatment of premenstrual dysphoric disorder (PMDD). However, to the best of our knowledge, there has been no study comparing the efficacy of the S